Recent advances on non-immunosuppressive treatment of IgA nephropathy
Immunoglobulin A nephropathy （IgAN） is one of the most common type of primary glomerulonephritis in China. Due to the lack of effective intervention means for the etiology， optimal supportive treatment is still the mainstream method at present. The uncertain efficacy and safety of new targeted immun...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2025-07-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2025.07.013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Immunoglobulin A nephropathy （IgAN） is one of the most common type of primary glomerulonephritis in China. Due to the lack of effective intervention means for the etiology， optimal supportive treatment is still the mainstream method at present. The uncertain efficacy and safety of new targeted immunosuppressive drugs limit the further clinical application. In recent years， non-immunosuppressive treatments have gradually garnered the attention of scholars. This article aims to review the progress of optimized lifestyle management， symptomatic supportive treatment， and traditional and novel non-immunosuppressive treatments of IgAN， thus offering new directions for medical practice. |
|---|---|
| ISSN: | 1671-2390 |